New study evaluates the risk for patients with HR+ breast cancer to temporarily hold endocrine therapy in order to get pregnant
Assessing the Benefit of Endocrine Therapy After Breast-Conserving Surgery in Patients with Ductal Carcinoma In Situ
A new study examines the use of a seven-gene predictive DCIS biosignature to assess when endocrine therapy may benefit patients following breast-conserving surgery.
No Survival Advantage from Chemo-endocrine Therapy over Endocrine Therapy in Invasive Lobular Carcinoma
The combination of adjuvant chemotherapy and endocrine therapy is no more effective than endocrine therapy alone in improving survival outcomes in patients with early-stage invasive lobular breast cancer, Cleveland Clinic investigators have found.
These Are the ASCO 2019 Abstracts That Will Make a Difference
What research abstracts presented at this year’s American Society of Clinical Oncology annual meeting will have the biggest potential impact on clinical practice? Cleveland Clinic Cancer Center physicians make their picks.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy